Alcon Laboratories, Inc., Alcon Pharmaceuticals Ltd & Alcon Management, SA

Parent Company:
Novartis (Switzerland)
HQ Country of Company:
USA
Agency:
OFAC & Bureau of Industry and Security
Location of Sentencing:
Washington D.C.
Date:
Description:
Alcon produced documents and information from which it appeared that from August 2008 to December 2011, Alcon violated the ITSR when it engaged in the sale and exportation of medical end-use surgical and pharmaceutical products from the United States to distributors located in Iran and Sudan without OFAC authorization.
Fine:
Total Fine
$7,617,150 (OFAC) + $8,100 (BIS)
Total Forefeiture
$ 0.00
Total Special Assessment
$ 0.00
Grand Total
$7,625,250.00
Source:
Treasury, “Enforcement Information For July 5, 2016.”
Back to Iran Violation and Penalties Tracker